BTIG Downgrades Intersect ENT (XENT) to Neutral, Following Acquisition
Tweet Send to a Friend
BTIG analyst Ryan Zimmerman downgraded Intersect ENT (NASDAQ: XENT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
